RESUMO
Carcinostatic effects of combined use of ascorbic acid (Asc), 2-O-phospho- or 6-O-palmitoyl ascorbate (Asc2Phos, Asc6Palm) or diverse alkanoyl Asc, and nano-sized platinum-poly(N-vinyl-pyrrolidone) colloid (PVP-Pt; 2-nm diameter) were examined on human esophagus carcinoma-derived cells KYSE70. Cell viability was repressed by 'Asc6Palm + PVP-Pt' mixture more markedly than by Asc6Palm or PVP-Pt alone, together with cell shrinkage and fragmentation, in contrast to no additive carcinostatic effect of 'Asc + PVP-Pt' or 'Asc2Phos + PVP-Pt'. The effects might be partly due to efficiency for intracellular uptake of PVP-Pt, as previously shown by our studies that Pt atoms composed of PVP-Pt were incorporated into human tongue carcinoma cells by 9.6-fold compared to normal human tongue epitheliocytes. Asc6Palm was advantageous for intracellular uptake, in terms of the proper balance for molecular hydrophilicity-lipophilicity (BMHL), whereas 6-O-stearoyl (C18) Asc or 2,6-O-dipalmitoyl (2 × C16) was demonstrated to be less carcinostatic owing to a lower BMHL. Although esterolytically converted from Asc6Palm, Asc was necessitated to be retained for efficient carcinostasis, and demonstrated by HPLC-coulometric ECD analysis to be appreciably stabilized in electrolytically generated hydrogen (dissolved hydrogen: 0.575 mg/L)-water, but scarcely in hydrogen-gas-bubbled water (0.427 mg/L), Mg stick-derived hydrogen (0.044 mg/L) water, or tap water, suggesting that hydrogen-rich water suppresses oxidative decomposition of Asc. Thus, Asc6Palm plus PVP-Pt with hydrogen-rich water supplement might be applicable for carcinostatic therapy.
Assuntos
Antineoplásicos/farmacologia , Ácido Ascórbico/farmacologia , Carcinoma de Células Escamosas/patologia , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Coloides/farmacologia , Neoplasias Esofágicas/patologia , Hidrogênio/farmacologia , Nanocompostos , Antineoplásicos/uso terapêutico , Ácido Ascórbico/química , Ácido Ascórbico/uso terapêutico , Carcinoma de Células Escamosas/tratamento farmacológico , Linhagem Celular Tumoral , Coloides/química , Coloides/uso terapêutico , Neoplasias Esofágicas/tratamento farmacológico , Humanos , Hidrogênio/uso terapêutico , Platina/farmacologia , ÁguaRESUMO
The objective of this study was to compare the efficacy of supportive periodontal therapy (i.e. scaling and rooth planning, SRP) alone versus a chemical device silica dioxide (SiO2) colloidal solutions (SDCS) used in association with SRP in the treatment of chronic periodontitis in adult patients. A total of 20 patients with a diagnosis of chronic periodontitis (40 localized chronic periodontitis sites) in the age group of 35 to 55 were selected. None of these patients have previously received any surgical or non-surgical periodontal therapy and demonstrated radiographic evidence of moderate bone loss. Two non-adjacent sites in separate quadrants were selected in each patient to monitorize treatment efficacy (split mouth design). Clinical pocket depth (PD) and microbial analysis (MA) were analyzed at baseline and 15th day. SPSS program and paired simple statistic T-test were used to detect significant differences. Total bacteria loading, Tannerella Forsitia and Treponema Denticola loading were statistically reduced when SiO2 is locally delivered. SDCS gel is an adjuvant therapy which should be added to SRP in the management of moderate to severe chronic periodontitis.
Assuntos
Periodontite Crônica/tratamento farmacológico , Coloides/uso terapêutico , Dióxido de Silício/uso terapêutico , Adulto , Estudos de Casos e Controles , Raspagem Dentária , Humanos , Pessoa de Meia-Idade , Bolsa Periodontal , Aplainamento Radicular , Resultado do TratamentoRESUMO
Recognition of fluid creep has driven a large amount of the scientific investigation in the area of acute fluid resuscitation for burn patients. The role of colloids in ameliorating fluid creep is controversial, despite the fact that a fluid-sparing effect of colloids has been recognized for some time. All but one of the available prospective studies using colloids are more than a decade old, and a modern randomized controlled trial (RCT) comparing crystalloids to colloids is long overdue. While urinary output continues to be the main endpoint for fluid titration, there has been a moderate amount of interest in the use of transpulmonary thermodilution to guide fluid resuscitation. The available studies have found that transpulmonary thermodilution has had an inconsistent effect on limiting fluid resuscitation volumes and improving clinical outcomes. Computerized Decision Support Systems show great promise in optimizing fluid titration and reducing fluid resuscitation volumes, and an RCT comparing Computerized Decision Support Systems with conventional titration approaches will be the important next step. Use of high-dose vitamin C (ascorbic acid) has become a popular approach to limit fluid resuscitation volumes and edema formation, but it has been investigated in only two clinical studies: one a pseudo-randomized prospective study and the other a retrospective study. Improvements in clinical outcome have not been convincingly demonstrated, and concerns persist surrounding the possibility of induction of an osmotic diuresis, leading to intravascular volume depletion. An RCT is urgently required to evaluate high-dose vitamin C as an adjunct to crystalloid resuscitation compared with the use of crystalloids alone.
Assuntos
Queimaduras/terapia , Hidratação/métodos , Ácido Ascórbico/uso terapêutico , Coloides/uso terapêutico , Soluções Cristaloides , Humanos , Soluções Isotônicas/uso terapêutico , Termodiluição/métodosRESUMO
Currently, the aim of the resuscitation of burn patients is to maintain end-organ perfusion with fluid intake as minimal as possible. To avoid excess intake, we can improve the estimation using computer methods. Parkland and Brooke are the commonly used formulas, and recently, a new, an easy formula is been used, i.e. the Rule of TEN. Fluid resuscitation should be titrated to maintain the urine output of approximately 30-35 mL/h for an average-sized adult. The most commonly used fluids are crystalloid, but the phenomenon of creep flow has renewed interest in albumin. In severely burn patients, monitoring with transpulmonary thermodilution together with lactate, ScvO2 and intraabdominal pressures is a good option. Nurse-driven protocols or computer-based resuscitation algorithms reduce the dependence on clinical decision making and decrease fluid resuscitation intake. High-dose vitamin C, propranolol, the avoidance of excessive use of morphine and mechanical ventilation are other useful resources
El objetivo de la reanimación de los pacientes quemados es mantener la perfusión tisular con el menor aporte de fluidos posible. Para evitar un aporte excesivo podemos usar métodos de estimación computarizados. La fórmula de Parkland y la de Brooke son las más usadas y recientemente se ha propuesto una fórmula sencilla que es la «regla de los diez». Los fluidos de reanimación deben intentar mantener una diuresis de 30-35ml/h. Los fluidos más usados son los cristaloides, pero el fenómeno del «fluid creep» ha renovado el interés por el uso de la albúmina. En pacientes quemados críticos, la monitorización con termodilución transpulmonar junto con lactato, SvcO2 y presión intraabdominal es una buena opción. Protocolos de enfermería y algoritmos de reanimación informáticos reducen la dependencia de las decisiones de los clínicos y disminuyen el aporte requerido. Otras actuaciones útiles son: usar altas dosis de vitamina C, emplear propranolol y evitar el uso excesivo de morfina y de ventilación mecánica
Assuntos
Humanos , Queimaduras/terapia , Estado Terminal/terapia , Ressuscitação/métodos , Hidratação/métodos , Primeiros Socorros/métodos , Coloides/uso terapêutico , Agentes Molhantes/uso terapêuticoRESUMO
PURPOSE: Third-generation hydroxyethyl starch (HES) 130/0.4 has a larger dose limitation (up to 50 mL/kg/day) than HES 70/0.5 (up to 1000 mL/day) which has been used in Japan for 40 years. The aim of this study was to survey the current intraoperative blood transfusion and volume therapy and to predict the possible reduction of intraoperative albumin consumption assuming further replacement by HES 130/0.4 using data obtained from a survey by the Japanese Society of Anesthesiologists (JSA), although HES130/0.4 was not launched in Japan during this survey period. METHODS: In a JSA survey conducted at JSA-certified hospitals, 12,856 patients with a certain amount of blood loss were analyzed for 1 month (April, 2012). The patients were divided into two groups-group A included patients aged ≥11 years and group B included patients aged <10 years. The possible lower volume of intraoperative albumin was calculated assuming that HES 130/0.4 was used up to a dose of 50 mL/kg. RESULTS: Blood loss (total 15,111 L; 15,057 L in group A and 54 L in group B) was treated with allogeneic transfusion (total 7970 L; 7893 L in group A and 77 L in group B) and auto-transfusion (total 1777 L; 1771 L in group A and 6 L in group B) in both groups (n = 11,670 and 119). Albumin (total 1391 L; 1376 L in group A and 15 L in group B), and HES 70/0.5 (total 7645 L; 7638 L in group A and 7 L in group B) were used in both groups (n = 10,850 and 116). Five percent and 4.4 % albumin (total 1189 L; 1180 L in group A and 9 L in group B) could be replaced by HES 130/0.4 if HES 130/0.4 had been used up to a dose of 50 mL/kg. CONCLUSION: Blood loss (15,111 L) was replaced with allogeneic transfusion (53 %), auto-transfusion (12 %), albumin (9 %) and HES 70/0.5 (51 %) during surgery in April 2012. The predicted volume of 5 and 4.4 % albumin saved during this 1-month period if HES 130/0.4 had been used up to a dose of 50 mL/kg was 1189 L (86 % of actual amount used).
Assuntos
Transfusão de Sangue/estatística & dados numéricos , Coloides/uso terapêutico , Cirurgia Geral/estatística & dados numéricos , Hospitais/estatística & dados numéricos , Substitutos do Plasma/uso terapêutico , Albumina Sérica , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anestesiologia/estatística & dados numéricos , Perda Sanguínea Cirúrgica , Transfusão de Sangue Autóloga/estatística & dados numéricos , Criança , Pré-Escolar , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Derivados de Hidroxietil Amido/uso terapêutico , Lactente , Recém-Nascido , Japão , Masculino , Pessoa de Meia-Idade , Adulto JovemRESUMO
Intravenous fluid administration is a medical intervention performed worldwide on a daily basis. Nevertheless, only a few physicians are aware of the characteristics of intravenous fluids and their possible effects on plasma acid-base equilibrium. According to Stewart's theory, pH is independently regulated by three variables: partial pressure of carbon dioxide, strong ion difference (SID), and total amount of weak acids (ATOT). When fluids are infused, plasma SID and ATOT tend toward the SID and ATOT of the administered fluid. Depending on their composition, fluids can therefore lower, increase, or leave pH unchanged. As a general rule, crystalloids having a SID greater than plasma bicarbonate concentration (HCO3-) cause an increase in plasma pH (alkalosis), those having a SID lower than HCO3- cause a decrease in plasma pH (acidosis), while crystalloids with a SID equal to HCO3- leave pH unchanged, regardless of the extent of the dilution. Colloids and blood components are composed of a crystalloid solution as solvent, and the abovementioned rules partially hold true also for these fluids. The scenario is however complicated by the possible presence of weak anions (albumin, phosphates and gelatins) and their effect on plasma pH. The present manuscript summarises the characteristics of crystalloids, colloids, buffer solutions and blood components and reviews their effect on acid-base equilibrium. Understanding the composition of intravenous fluids, along with the application of simple physicochemical rules best described by Stewart's approach, are pivotal steps to fully elucidate and predict alterations of plasma acid-base equilibrium induced by fluid therapy.
Assuntos
Equilíbrio Ácido-Base/efeitos dos fármacos , Transfusão de Componentes Sanguíneos/efeitos adversos , Transfusão de Componentes Sanguíneos/métodos , Coloides/efeitos adversos , Coloides/uso terapêutico , Soluções Isotônicas/efeitos adversos , Soluções Isotônicas/uso terapêutico , Soluções/efeitos adversos , Soluções/uso terapêutico , Coloides/administração & dosagem , Soluções Cristaloides , Hidratação , Humanos , Infusões Intravenosas , Soluções Isotônicas/administração & dosagem , Soluções/administração & dosagem , Água/metabolismoRESUMO
BACKGROUND: Fluid resuscitation is the cornerstone of sepsis treatment. However, whether balanced or unbalanced crystalloids or natural or synthetic colloids confer a survival advantage is unclear. PURPOSE: To examine the effect of different resuscitative fluids on mortality in patients with sepsis. DATA SOURCES: MEDLINE, EMBASE, ACP Journal Club, CINAHL, HealthSTAR, the Allied and Complementary Medicine Database, and the Cochrane Central Register of Controlled Trials through March 2014. STUDY SELECTION: Randomized trials that evaluated different resuscitative fluids in adult patients with sepsis or septic shock and death. No language restrictions were applied. DATA EXTRACTION: Two reviewers extracted data on study characteristics, methods, and outcomes. Risk of bias for individual studies and quality of evidence were assessed. DATA SYNTHESIS: 14 studies (18916 patients) were included with 15 direct comparisons. Network meta-analysis at the 4-node level showed higher mortality with starches than with crystalloids (high confidence) and lower mortality with albumin than with crystalloids (moderate confidence) or starches (moderate confidence). Network meta-analysis at the 6-node level showed lower mortality with albumin than with saline (moderate confidence) and low-molecular-weight starch (low confidence) and with balanced crystalloids than with saline (low confidence) and low- and high-molecular-weight starches (moderate confidence). LIMITATIONS: These trials were heterogeneous in case mix, fluids evaluated, duration of fluid exposure, and risk of bias. Imprecise estimates for several comparisons in this network meta-analysis contribute to low confidence in most estimates of effect. CONCLUSION: Among patients with sepsis, resuscitation with balanced crystalloids or albumin compared with other fluids seems to be associated with reduced mortality. PRIMARY FUNDING SOURCE: The Hamilton Chapter of the Canadian Intensive Care Foundation and the Critical Care Medicine Residency Program and Critical Care Division Alternate Funding Plan at McMaster University.
Assuntos
Coloides/uso terapêutico , Hidratação , Soluções Isotônicas/uso terapêutico , Soluções para Reidratação/uso terapêutico , Sepse/terapia , Albuminas/uso terapêutico , Soluções Cristaloides , Gelatina/uso terapêutico , Humanos , Derivados de Hidroxietil Amido/uso terapêutico , Peso Molecular , Soluções para Reidratação/química , Solução Salina Hipertônica/uso terapêutico , Choque Séptico/terapiaRESUMO
PURPOSE: Dermatitis is a very frequent and distressing side effect of radiation therapy that may necessitate a treatment interruption when evolving towards more severe forms such as moist desquamation (MD). The aim of this study was to compare the efficacy of two topical agents, a dexpanthenol cream vs a hydroactive colloid gel combining absorbing and moisturising properties, in preventing MD in breast cancer patients. METHODS: This retrospective study compared two successive groups of breast cancer patients undergoing radiotherapy after breast-sparing surgery between 2008 and 2012. A group of 267 patients applied a 5% dexpanthenol cream on the irradiated zone throughout the course of their radiotherapy. Another group of 216 patients applied first the dexpanthenol cream then replaced it by the hydroactive colloid gel after 11-14 days of radiotherapy. Radiation treatment (total dose, technique, and equipment) was the same for the two groups. The clinical outcomes were the occurrence and time to onset of moist desquamation. KEY RESULTS: The overall incidence of MD was significantly lower in patients who applied the hydroactive colloid gel (16%) than in those who applied the dexpanthenol cream (32%, odds-ratio = 0.35). Also, MD occurred significantly later with the hydroactive colloid gel than with the dexpanthenol cream (hazard ratio = 0.39). CONCLUSIONS: Compared with the dexpanthenol cream, the hydroactive colloid gel significantly reduced the risk of developing MD in patients undergoing radiotherapy for breast cancer. These promising results warrant further research on the efficacy of hydroactive colloid gels in managing radiation dermatitis.
Assuntos
Neoplasias da Mama/radioterapia , Coloides/uso terapêutico , Ceratolíticos/uso terapêutico , Ácido Pantotênico/análogos & derivados , Radiodermite/tratamento farmacológico , Radiodermite/etiologia , Radioterapia Adjuvante/efeitos adversos , Administração Tópica , Adulto , Idoso , Feminino , Géis/uso terapêutico , Humanos , Pessoa de Meia-Idade , Ácido Pantotênico/uso terapêutico , Estudos Retrospectivos , Resultado do TratamentoRESUMO
Mesoporous magnetic colloidal nanocrystal clusters (MCNCs) are featured with high magnetization, adequate surface area, excellent colloidal stability, good biocompatibility, and acid degradability. It is thus highly anticipated that MCNCs can serve as vehicles for target drug delivery. Herein, the mesoporous MCNCs stabilized by poly(gamma-glutamic acid) (PGA) were fabricated by the modified solvothermal route, showing a high specific surface area (126.4 m2/g), strong magnetic response (63 emu/g) and appropriate mesoporosity including a large pore volume (0.27 cm3/g) and accessible pore size (8.1 nm). Docetaxel (DOC) was then loaded in the resultant MCNCs using the nanoprecipitation method, and a high drug loading capacity was achieved up to 24 wt%. The chemotherapeutic effect and mechanism of DOC-MCNC conjugates in bladder cancer was evaluated in vitro. A series of analyses for cell uptake, cell viability, cell cycle, cell apoptosis and some cell proteins were performed by transmission electron microscopy, MTT assay, flow cytometry, cell nuclei staining, Annexin V staining assay, western blot assay and caspase-3 activity assay, respectively. The results demonstrated that DOC-MCNC conjugates enhanced the inhibitory effect by hampering mitoschisis and increased the apoptotic effect by changing the expression of apoptosis-related proteins in T24 cells, substantially proving their remarkable efficiency in treatment of bladder cancer.
Assuntos
Antineoplásicos/administração & dosagem , Apoptose/efeitos dos fármacos , Nanopartículas de Magnetita/uso terapêutico , Nanopartículas/uso terapêutico , Taxoides/administração & dosagem , Neoplasias da Bexiga Urinária/tratamento farmacológico , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Coloides/química , Coloides/uso terapêutico , Docetaxel , Portadores de Fármacos/química , Portadores de Fármacos/uso terapêutico , Avaliação Pré-Clínica de Medicamentos , Humanos , Nanopartículas de Magnetita/química , Nanopartículas/química , Ácido Poliglutâmico/análogos & derivados , Ácido Poliglutâmico/química , Ácido Poliglutâmico/uso terapêutico , Porosidade , Neoplasias da Bexiga Urinária/patologiaRESUMO
There has been increased interest in the role of anti-Proteus antibodies in the aetiology of rheumatoid arthritis (RA) and whether chemotherapeutic agents active against Proteus species might reduce the risk and/or exacerbations of RA. We examined the in vitro antibacterial effects of ten different silver preparations which were either ionic silver [Ag(I)] solutions or nanoparticulate silver (NPS) (Ag(0)) suspensions against ATCC and two wild (clinical) strains of Proteus. The data establish the low minimum inhibitory concentration and minimum bactericidal concentration of all the silver formulations tested against these four Proteus strains. In a pilot study, a potent NPS preparation ex vivo showed long-lasting anti-Proteus activity in a normal human volunteer.
Assuntos
Antibacterianos/uso terapêutico , Artrite Reumatoide/microbiologia , Coloides/uso terapêutico , Soluções Farmacêuticas/uso terapêutico , Proteus/efeitos dos fármacos , Sais/uso terapêutico , Prata/uso terapêutico , Artrite Reumatoide/etiologia , Humanos , Nanopartículas Metálicas/uso terapêutico , Testes de Sensibilidade Microbiana/métodos , Projetos Piloto , Suspensões/uso terapêuticoRESUMO
Over 90% of iron deficiency anemia cases are due to iron deficiency associated with depletion of stored iron or inadequate intake. Parenteral iron supplementation is an important part of the management of anemia, and some kinds of intravenous iron are used. However, few studies have evaluated the clinical efficacy of these drugs. The purpose of this study was to compare and assess the clinical efficacy of two types of intravenous iron injection, saccharated ferric oxide (SFO) and cideferron (CF). Medical records were obtained for 91 unrelated Japanese anemia patients treated with SFO (n = 37) or CF (n = 54) from May 2005 to May 2010 at Gunma University Hospital. Patients treated with blood transfusion, erythropoietin or oral iron were excluded. Hemoglobin (Hb) values measured on day 0, 7 and 14 were used to assess the efficacy of intravenous irons. A significant increase was observed in the mean Hb value by day 14 of administration in both the CF group and SFO group, and the mean Hb increase due to administration of CF for 7 days was comparable to that of SFO for 14 days. Age and sex did not affect improvement of Hb value. CF is fast acting and highly effective compared with SFO for the treatment of iron deficiency anemia. The use of CF may shorten a therapeutic period for iron deficiency anemia, and CF may be feasible for reducing the hospitalization period.
Assuntos
Anemia Hipocrômica/tratamento farmacológico , Coloides/uso terapêutico , Meios de Contraste/uso terapêutico , Compostos Férricos/uso terapêutico , Ácido Glucárico/uso terapêutico , Ferro/uso terapêutico , Idoso , Envelhecimento/fisiologia , Povo Asiático , Coloides/administração & dosagem , Meios de Contraste/administração & dosagem , Feminino , Compostos Férricos/administração & dosagem , Óxido de Ferro Sacarado , Ácido Glucárico/administração & dosagem , Hemoglobinas/análise , Hemoglobinas/metabolismo , Humanos , Injeções Intravenosas , Ferro/administração & dosagem , Masculino , Pessoa de Meia-Idade , Caracteres SexuaisAssuntos
Hidratação/métodos , Soluções Hipotônicas/uso terapêutico , Soluções Isotônicas/uso terapêutico , Anestesia , Criança , Pré-Escolar , Coloides/administração & dosagem , Coloides/uso terapêutico , Solução Hipertônica de Glucose/administração & dosagem , Solução Hipertônica de Glucose/uso terapêutico , Humanos , Soluções Hipotônicas/administração & dosagem , Soluções Hipotônicas/química , Lactente , Recém-Nascido , Infusões Intravenosas , Soluções Isotônicas/administração & dosagem , Soluções Isotônicas/química , Pediatria , Assistência PerioperatóriaRESUMO
BACKGROUND: The aim of this study was to investigate if colloid infusions have different effects on intestinal anastomotic healing when compared to crystalloid infusions depending on the amount of the administered volume. MATERIALS AND METHODS: Twenty-eight Wistar rats were randomly assigned to four groups receiving different amounts of either a crystalloid (Cry) or a colloid (Col) infusion solution. Animals with volume restriction (Cry (-) or Col (-)) were treated with a low and animals with volume overcharge (Cry (+) or Col (+)) with a high flow rate. All animals received an infusion for a 60-min period, while an end-to-end small bowel anastomosis was performed. At reoperation, the anastomotic bursting pressure (millimeters of mercury) was measured, as well as anastomotic hydroxyproline concentration. The presence of bowel wall edema was assessed histologically. RESULTS: Median bursting pressures were comparable in the Col (-) [118 mm Hg (range 113-170)], the Cry (-) [118 mm Hg (78-139)], and the Col (+) [97 mm Hg (65-152)] group. A significantly lower median bursting pressure was found in animals with crystalloid volume overload Cry (+) [73 mm Hg (60-101)]. Corresponding results were found for hydroxyproline concentration. Histology revealed submucosal edema in Cry (+) animals. CONCLUSIONS: In case of a fixed, high-volume load, colloids seem to have benefits on intestinal anastomotic healing when compared to crystalloid infusions.
Assuntos
Anastomose Cirúrgica/métodos , Coloides/uso terapêutico , Procedimentos Cirúrgicos do Sistema Digestório/métodos , Soluções Isotônicas/uso terapêutico , Animais , Coloides/administração & dosagem , Coloides/farmacologia , Soluções Cristaloides , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Edema , Hidroxiprolina , Soluções Isotônicas/administração & dosagem , Soluções Isotônicas/farmacologia , Pressão , Ratos , Ratos Wistar , Resultado do Tratamento , Cicatrização/efeitos dos fármacosRESUMO
Early volume resuscitation of a patient with sepsis has been shown to reduce morbidity, mortality, and healthcare resource consumption. Hypertonic saline offers a theoretically viable option for volume resuscitation. This article reviews the current information available regarding fluid resuscitation in patients with sepsis, with emphasis on the use of hypertonic saline.
Assuntos
Hidratação/métodos , Ressuscitação/métodos , Solução Salina Hipertônica/uso terapêutico , Sepse/terapia , Animais , Coloides/uso terapêutico , Cuidados Críticos/métodos , Soluções Cristaloides , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Humanos , Derivados de Hidroxietil Amido/uso terapêutico , Soluções Isotônicas/uso terapêutico , Seleção de Pacientes , Substitutos do Plasma/uso terapêutico , Volume Plasmático , Lactato de Ringer , Solução Salina Hipertônica/farmacologia , Cloreto de Sódio/uso terapêutico , Resultado do TratamentoAssuntos
Dermatite Atópica/tratamento farmacológico , Óleos de Plantas/química , Óleos de Plantas/uso terapêutico , Compostos de Prata/uso terapêutico , Animais , Coloides/administração & dosagem , Coloides/uso terapêutico , Humanos , Camundongos , Azeite de Oliva , Oxidantes Fotoquímicos/química , Ozônio/química , Óleos de Plantas/administração & dosagem , Compostos de Prata/administração & dosagemAssuntos
Volume Sanguíneo/efeitos dos fármacos , Estado Terminal/terapia , Transfusão de Eritrócitos/efeitos adversos , Transfusão de Sangue Autóloga , Coloides/uso terapêutico , Soluções Cristaloides , Transfusão de Eritrócitos/métodos , Transfusão de Eritrócitos/mortalidade , Transfusão de Eritrócitos/normas , Hemoglobinas/metabolismo , Humanos , Sistema Imunitário/efeitos dos fármacos , Inflamação/fisiopatologia , Soluções Isotônicas/uso terapêutico , Guias de Prática Clínica como Assunto , Albumina Sérica/uso terapêuticoRESUMO
Compensation of operation blood loss up to 10% of the circulating blood volume (CBV) by autohemotransfusion with intraoperative blood collection (33 patients) and infusion of colloid and crystalloid solutions (33 patients) was studied. It was shown that the intraoperative blood loss up to 10% of CBV resulted in statistically considerable changes in hemoglobin, packed cell volume, erythrocytes, and fibrinogen appearing by the moment of blood loss compensation; within 4-6 hours after surgery the changed clinical and hemostasiological indices caused by blood loss up to 10% of CBV were rapidly arrested by autohemotransfusion with the intraoperatively collected blood or infusion of colloid and crystalloid solutions. No advantages of autohemotransfusion with the intraoperatively collected blood over the infusion of colloid and crystalloid solutions were found in compensation of intraoperative blood loss up to 10% of CBV.
Assuntos
Perda Sanguínea Cirúrgica/prevenção & controle , Transfusão de Sangue Autóloga/métodos , Coloides/uso terapêutico , Cuidados Intraoperatórios , Complicações Intraoperatórias , Soluções Isotônicas/uso terapêutico , Adulto , Coloides/administração & dosagem , Soluções Cristaloides , Feminino , Humanos , Infusões Intravenosas , Soluções Isotônicas/administração & dosagem , MasculinoRESUMO
The Consensus Document on Alternatives to Allogenic Blood Transfusion (AABT) has been drawn up by a panel of experts from 5 scientific societies. The Spanish Societies of Anesthesiology (SEDAR), Critical Care Medicine and Coronary Units (SEMICYUC), Hematology and Hemotherapy (AEHH), Blood Transfusion (SETS) and Thrombosis and Hemostasis (SETH) have sponsored and participated in this Consensus Document. Alternatives to blood transfusion have been divided into pharmacological and non-pharmacological, with 4 modules and 12 topics. The main objective variable was the reduction of allogenic blood transfusions and/or the number of transfused patients. The extent to which this objective was achieved by each AABT was evaluated using the Delphi method, which classifies the grade of recommendation from A (supported by controlled studies) to E (non-controlled studies and expert opinion). The experts concluded that most of the indications for AABT were based on middle or low grades of recommendation, "C", "D", or "E", thus indicating the need for further controlled studies.
Assuntos
Hemorragia/terapia , Ácido Aminocaproico/administração & dosagem , Ácido Aminocaproico/efeitos adversos , Ácido Aminocaproico/uso terapêutico , Antifibrinolíticos/administração & dosagem , Antifibrinolíticos/efeitos adversos , Antifibrinolíticos/uso terapêutico , Aprotinina/administração & dosagem , Aprotinina/efeitos adversos , Aprotinina/uso terapêutico , Perda Sanguínea Cirúrgica/prevenção & controle , Substitutos Sanguíneos/administração & dosagem , Substitutos Sanguíneos/efeitos adversos , Substitutos Sanguíneos/uso terapêutico , Transfusão de Sangue Autóloga , Coloides/administração & dosagem , Coloides/efeitos adversos , Coloides/uso terapêutico , Soluções Cristaloides , Desamino Arginina Vasopressina/administração & dosagem , Desamino Arginina Vasopressina/efeitos adversos , Desamino Arginina Vasopressina/uso terapêutico , Medicina Baseada em Evidências , Fator VIIa/administração & dosagem , Fator VIIa/efeitos adversos , Fator VIIa/uso terapêutico , Hematínicos/administração & dosagem , Hematínicos/efeitos adversos , Hematínicos/uso terapêutico , Hemodiluição , Hemorragia/tratamento farmacológico , Hemostáticos/administração & dosagem , Hemostáticos/efeitos adversos , Hemostáticos/uso terapêutico , Humanos , Ferro/administração & dosagem , Ferro/efeitos adversos , Ferro/uso terapêutico , Soluções Isotônicas/administração & dosagem , Soluções Isotônicas/efeitos adversos , Soluções Isotônicas/uso terapêutico , Recuperação de Sangue Operatório , Hemorragia Pós-Operatória/tratamento farmacológico , Pré-Medicação , Ensaios Clínicos Controlados Aleatórios como Assunto/estatística & dados numéricos , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/efeitos adversos , Proteínas Recombinantes/uso terapêutico , Ácido Tranexâmico/administração & dosagem , Ácido Tranexâmico/efeitos adversos , Ácido Tranexâmico/uso terapêuticoRESUMO
BACKGROUND: Recently there have appeared on the market many external dressings for wound management. They all use water-sealing materials to maintain wounds in a moist state. However, in our daily clinical observations, a water-sealing material sometimes results in poor wound healing. Although a water-sealing material does in fact keep the wound moist, the quality of the water is far from that of the optimum extracellular fluid. METHODS: A second-degree burn wound was made in the rat by contact with a metal stick. Experiment 1 was to evaluate the influence of delayed primary wound treatment on burn-wound depth progression. We used a time lag procedure. Each group was treated with a water-sealing application (hydrocolloid sheet). Experiment 2 was to investigate the progression-preventing effect of normal saline on a burn allowed to dry for 3 hours, we compared a group that received a water sealing (non-moistening and incomplete moisture) dressing with one that received a water-supplying (moistening) dressing with using chi-square test. RESULTS: In the Experiment 1 (time lag and water sealing test), the early group showed quite normal wound healing at 7 days after onset. The slough was thin (about 10-20% of full dermal thickness). The delayed groups showed the poor healing characteristic. The slough was relatively thick (about 30-60% of full dermal thickness). Three hours' delay seemed to bring about poor healing. In the Experiment 2 (water application test), the moistening (water application) group showed relatively good healing after seven days. The slough was as thin as in the early group in the Experiment 1. The non-moistening group showed a poor healing process like the delayed group in the Experiment 1. For the moistening group, the healing percentage of 77.8% was significantly greater than the 41.3% observed in the non-moistening group (chi-square test, p < 0.05). CONCLUSIONS: All the materials in wound dressing are water-sealing. When the component water under the sheet is far from the extracellular fluid, these applications bring about poor healing. Delayed application and incomplete moisture should be corrected by external water-application.